The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection
Open accessAbstract
Helicobacter pylori infection of the gastric mucosa can be found in approximately 50% of the world's population and is associated with a range of pathology, including peptic ulcer, atrophic gastritis, and gastric cancer. To explore immunization as a strategy for preventing and treating H. pylori -associated disease, we assessed the safety and immunogenicity in healthy adults of a formalin-inactivated, oral H. pylori whole-cell (HWC) vaccine, administered with or without mutant Escherichia coli heat-labile toxin (LT R192G ) as a mucosal adjuvant. In a dose-response study, 23 subjects with or without H. pylori infection were vaccinated with either 2.5 × 10 6 HWC, 2.5 × 10 8 HWC, or 2.5 × 10 10 HWC, plus 25 μg of LT R192G . Thereafter, a randomized study was conducted in which 18 H. pylori -infected subjects were assigned, in a double-blind fashion, to receive either 2.5 × 10 10 HWC plus placebo-adjuvant, placebo-vaccine plus 25 μg of LT R192G , placebo-vaccine plus placebo-adjuvant, or 2.5 × 10 10 HWC plus 25 μg of LT R192G . Diarrhea (six subjects), low-grade fever (five subjects), and vomiting (two subjects) were observed, usually after the first dose. Significant rises in geometric mean mucosal (fecal and salivary) anti-HWC immunoglobulin A antibodies occurred among H. pylori -infected and uninfected subjects following inoculation with 2.5 × 10 10 HWC plus 25 μg of LT R192G . Moreover, among H. pylori -negative volunteers, this regimen induced significant lymphoproliferative responses in 5 of 10 subjects and gamma interferon production responses to H. pylori sonicate in 7 of 10 subjects. There was no evidence that vaccination eradicated H. pylori in infected volunteers. These results suggest that it is possible to stimulate mucosal and systemic immune responses in humans to H. pylori antigens by using an HWC vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cure of duodenal ulcer associated with eradication of Helicobacter pylori
Rauws, E. A. J., & Tytgat, G. N. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91301-p · Cited by 922 · cited 2×
“pylori infection from the stomach with antimicrobial therapy heals chronic gastritis and peptic ulcers, prevents ulcers from recurring (25, 31, 47, 55) and may lead to regression of gastric lymphoma (50, 65).”
BackgroundGraham, D. Y., Lew, G. M., Klein, P. D., Evans, D. G., Evans, D. J., Saeed, Z. A., & Malaty, H. M. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-9-705 · Cited by 909 · cited 2×
“pylori infection from the stomach with antimicrobial therapy heals chronic gastritis and peptic ulcers, prevents ulcers from recurring (25, 31, 47, 55) and may lead to regression of gastric lymphoma (50, 65).”
Background
Cited by
Zeng, M., Mao, X.-H., Li, J.-X., Tong, W.-D., Wang, B., Zhang, Y.-J., Guo, G., Zhao, Z.-J., Li, L., Wu, D.-L., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60310-5 · Cited by 305
Wilson, K. T., & Crabtree, J. E. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.008 · Cited by 278
Norton, E. B., Lawson, L. B., Freytag, L. C., & Clements, J. D. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00538-10 · Cited by 221
The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
Clements, J. D., & Norton, E. B. (2018) · mSphere · doi:10.1128/msphere.00215-18 · Cited by 177
Metadata
- Authors
- Kotloff, K. L., Sztein, M. B., Wasserman, S. S., Losonsky, G. A., DiLorenzo, S. C., & Walker, R. I.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2001-06
- Volume
- 69
- Issue
- 6
- Pages
- 3581-3590
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2125437451
- Cited by
- 201
- References
- 2
- FWCI
- 15.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection. https://app.cochat.ai/papers/10.1128/iai.69.6.3581-3590.2001
- The paper
- Kotloff, K. L., Sztein, M. B., Wasserman, S. S., Losonsky, G. A., DiLorenzo, S. C., & Walker, R. I. (2001). Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection. Infection and Immunity. https://doi.org/10.1128/iai.69.6.3581-3590.2001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.